< Back to situations

[ORGANIZATION]

Merck & Co., Inc.

Featured in 12 tracked stories · first seen

Situations

[ACTIVE] [BUSINESS] [DE] [US] [CN]

Global EV market shifts and infrastructure challenges

42 clusters · 320 sources · last updated

Latest: Tesla beats third-quarter delivery estimates

By early October 2026, the global electric vehicle (EV) market has reached a significant milestone, with battery-electric vehicles (BEVs) accounting for approximately 20% of all new car registrations in August. When incl

[ACTIVE] [BUSINESS] [US] [CN] [ES]

Moderna and Merck melanoma vaccine clinical trials

16 clusters · 450 sources · last updated

Latest: Moderna expands cancer therapy ties and benefits from vaccine program news

Moderna and Merck (MSD) have reported positive Phase 3 clinical trial results for intismeran autogene (V940), an experimental personalized mRNA cancer vaccine. The INTerpath-001 trial, which administered the vaccine alon

[ACTIVE] [TECHNOLOGY] [GB] [IN] [US]

AI-driven drug discovery and regulatory integration

17 clusters · 53 sources · last updated

Latest: Biopharmaceutical leaders call for European investment and AI oversight

By late September 2026, the pharmaceutical industry has transitioned from pilot programs to full-scale execution, focusing on integrating AI with real-time experimental data to create a ‘data closed loop’. Major partners

Also covered in